Rani Therapeutics Holdings, Inc. (RANI) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
RANI currently has 99.7M outstanding shares. with significant dilution risk as 311M authorized shares could dilute existing holders by 312.3%. The company has significantly diluted shareholders by 163.44% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Mar 26, 2026 |
10-K filing | 99.7M shares outstanding |
100M | 310M |
| Nov 07, 2025 |
S-3 filing: This prospectus relates to the proposed resale from time to time by the selling stockholders of up to 42,633,337 shares of our Class A common stock; up to 125,000,004 shares of our Class A common stock issuable upon the exercise of outstanding common stock warrants; and up to 82,366,667 shares of our Class A common stock issuable upon the exercise of outstanding pre-funded warrants. |
98M | 310M |
| Nov 06, 2025 |
10-Q filing | 97.5M shares outstanding |
98M | 61M |
| Aug 08, 2025 |
S-3 filing: The filing is an S-3 registration statement for the potential offering of up to $200,000,000 in aggregate amount of Class A common stock, preferred stock, debt securities, or warrants, either individually or in combination. |
48M | 61M |
| Aug 07, 2025 |
10-Q filing | 47.9M shares outstanding |
48M | 61M |
| Jul 03, 2025 |
S-3 filing: This S-3 filing relates to the proposed resale from time to time by the selling stockholder of up to 13,160,172 shares of Class A common stock issuable upon exercise of a Series D common stock warrant. |
33M | 61M |
| May 13, 2025 |
10-Q filing | 33.4M shares outstanding |
33M | 48M |
| Mar 31, 2025 |
10-K filing | 33.5M shares outstanding |
34M | 48M |
| Nov 14, 2024 |
10-Q filing | 33.3M shares outstanding |
33M | 48M |
| Aug 06, 2024 |
10-Q filing | 29.3M shares outstanding |
29M | 48M |
| May 06, 2024 |
10-Q filing | 26.0M shares outstanding |
26M | 48M |
| Mar 20, 2024 |
10-K filing | 26.0M shares outstanding |
26M | 48M |
| Nov 08, 2023 |
10-Q filing | 25.6M shares outstanding |
26M | 48M |
| Aug 11, 2023 |
10-Q filing | 25.3M shares outstanding |
25M | 48M |
| May 10, 2023 |
10-Q filing | 25.2M shares outstanding |
25M | 48M |
| Mar 22, 2023 |
10-K filing | 25.3M shares outstanding |
25M | 48M |
| Dec 16, 2022 |
S-3 filing: This prospectus relates to the resale from time to time of up to 6,009,542 shares of Class A common stock held by selling stockholders. The company will not receive any proceeds from the sale of these shares. |
24M | 48M |
| Nov 10, 2022 |
10-Q filing | 24.5M shares outstanding |
24M | 42M |
| Aug 10, 2022 |
10-Q filing | 24.4M shares outstanding |
24M | 42M |
| Aug 01, 2022 |
S-3 filing: The filing is an S-3 prospectus for a shelf offering of up to $400,000,000 in a combination of securities, including Class A common stock, preferred stock, and debt securities. The specific terms of the offerings will be detailed in prospectus supplements. |
24M | 42M |
| May 11, 2022 |
10-Q filing | 24.5M shares outstanding |
24M | 6.7M |
| Mar 31, 2022 |
10-K filing | 24.4M shares outstanding |
24M | 6.7M |
| Nov 16, 2021 |
10-Q filing | 19.7M shares outstanding |
20M | 6.7M |
| Sep 13, 2021 |
10-Q filing | 29.3M shares outstanding |
29M | 6.7M |
| Jul 26, 2021 |
S-1/A filing: This is an S-1/A filing for the initial public offering of Class A common stock of Rani Therapeutics Holdings, Inc. The company is offering 6,666,667 shares with an estimated price range of $14.00 to $16.00 per share. |
N/A | 6.7M |
| Jul 16, 2021 |
S-1/A filing: This is an S-1/A filing for Rani Therapeutics Holdings, Inc. registering Class A common stock with a proposed maximum aggregate offering price of $100,000,000. |
N/A | 0 |